Latest close: below its 200-day averageSep 8, 2026what changed →
Is the price fair?
What ATR's price assumes
AptarGroup, Inc. trades at 22.4× earnings against 40.2× for the median Medical Instruments & Supplies name, cheaper than its own group.
22.4
Trailing P/E · Medical Instruments & Supplies median 40.2 · cheaper than the typical name in its group
- Price / sales
- 2.10
Price / sales · as of 2026-Q1
- Free cash flow yield
- 3.9%
Free cash flow yield · Medical Instruments & Supplies median 3.7%
- Growth the price implies
- +9.1%
Growth the price implies · The price pays for +9.1% free cash flow growth a year for a decade; the business has delivered +23% a year over the last three.
Details›
- Price / book2026-Q1
- 3.09
- Healthcare median P/E362 names
- 29.9
- Medical Instruments & Supplies median P/E29 names
- 40.2
- Free cash flow, trailing twelve months
- $310M
- Market capitalisation
- $8.07B
- 3-year revenue growth
- +5.1%
- 3-year free cash flow growth
- +23%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $140.80 |
| Its own P/E history, median | $162.14 |
| Its own P/E history, upper quartile | $172.81 |
| 52-week range | $111.94 – $145.15 |
| Today | $124.37 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #6 of 19 by Smart Score